Opinion|Videos|July 12, 2024

MajesTEC-1 and the Value of Long-Term Follow-Up Data from ASCO 2024

Dr Garfall, MD, provides further insights around the MajesTEC-1 study.

Video content above is prompted by the following:

  • Please provide your key takeaways from this study. How do these updated results impact the potential use of teclistamab in the management of RRMM?
  • What is the value of long-term follow-up data in multiple myeloma? How does this impact treatment regimens?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo